Geethanjali Dornadula

2.6k total citations
30 papers, 1.9k citations indexed

About

Geethanjali Dornadula is a scholar working on Virology, Infectious Diseases and Epidemiology. According to data from OpenAlex, Geethanjali Dornadula has authored 30 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Virology, 21 papers in Infectious Diseases and 8 papers in Epidemiology. Recurrent topics in Geethanjali Dornadula's work include HIV Research and Treatment (24 papers), HIV/AIDS drug development and treatment (17 papers) and HIV/AIDS Research and Interventions (7 papers). Geethanjali Dornadula is often cited by papers focused on HIV Research and Treatment (24 papers), HIV/AIDS drug development and treatment (17 papers) and HIV/AIDS Research and Interventions (7 papers). Geethanjali Dornadula collaborates with scholars based in United States. Geethanjali Dornadula's co-authors include Roger J. Pomerantz, Hui Zhang, H Zhang, Joseph Kulkosky, Jeanette Roman, Maria Beumont, Kelly Henning, Michael R. Boyd, Matthias J. Schnell and Derek M. Culnan and has published in prestigious journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and JAMA.

In The Last Decade

Geethanjali Dornadula

30 papers receiving 1.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Geethanjali Dornadula United States 20 1.5k 1.2k 435 420 344 30 1.9k
Nafees Ahmad United States 22 1.2k 0.8× 915 0.7× 366 0.8× 450 1.1× 360 1.0× 55 1.8k
Jennifer C. Learmont Australia 13 1.6k 1.1× 905 0.7× 714 1.6× 264 0.6× 459 1.3× 20 1.8k
Alison L. Greenway Australia 14 1.4k 1.0× 709 0.6× 747 1.7× 401 1.0× 406 1.2× 23 1.8k
Anthony Hoffman United States 10 1.1k 0.8× 670 0.5× 764 1.8× 293 0.7× 386 1.1× 11 1.8k
F Clavel France 17 1.6k 1.1× 1.1k 0.9× 408 0.9× 565 1.3× 481 1.4× 25 2.1k
Anne Ellett Australia 20 1.6k 1.0× 835 0.7× 712 1.6× 341 0.8× 354 1.0× 29 1.8k
Åsa Björndal Sweden 16 1.9k 1.3× 1.2k 0.9× 940 2.2× 383 0.9× 336 1.0× 24 2.2k
JoAnn Kuruc United States 22 1.6k 1.1× 1.2k 1.0× 581 1.3× 413 1.0× 495 1.4× 40 2.1k
David J. Hooker Australia 10 1.1k 0.7× 668 0.5× 435 1.0× 247 0.6× 314 0.9× 14 1.3k
Yolanda Lie United States 22 1.4k 0.9× 1.4k 1.1× 175 0.4× 565 1.3× 290 0.8× 57 2.0k

Countries citing papers authored by Geethanjali Dornadula

Since Specialization
Citations

This map shows the geographic impact of Geethanjali Dornadula's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Geethanjali Dornadula with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Geethanjali Dornadula more than expected).

Fields of papers citing papers by Geethanjali Dornadula

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Geethanjali Dornadula. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Geethanjali Dornadula. The network helps show where Geethanjali Dornadula may publish in the future.

Co-authorship network of co-authors of Geethanjali Dornadula

This figure shows the co-authorship network connecting the top 25 collaborators of Geethanjali Dornadula. A scholar is included among the top collaborators of Geethanjali Dornadula based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Geethanjali Dornadula. Geethanjali Dornadula is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Dornadula, Geethanjali, et al.. (2024). Correlating Stability-Indicating Biochemical and Biophysical Characteristics with In Vitro Cell Potency in mRNA LNP Vaccine. Vaccines. 12(2). 169–169. 7 indexed citations
2.
Xu, Jenny, et al.. (2023). Development and qualification of cell-based relative potency assay for a human respiratory syncytial virus (RSV) mRNA vaccine. Journal of Pharmaceutical and Biomedical Analysis. 234. 115523–115523. 7 indexed citations
3.
Wang, Su, Richard R. Rustandi, Feng Wang, et al.. (2014). Detecting and preventing reversion to toxicity for a formaldehyde-treated C. difficile toxin B mutant. Vaccine. 33(1). 252–259. 12 indexed citations
4.
Roman, Jeanette, et al.. (2010). Application of miniaturized immunoassays to discovery pharmacokinetic bioanalysis. Journal of Pharmacological and Toxicological Methods. 63(3). 227–235. 35 indexed citations
5.
Argyris, Elias G., Geethanjali Dornadula, Giuseppe Nunnari, et al.. (2006). Inhibition of endogenous reverse transcription of human and nonhuman primate lentiviruses: Potential for development of lentivirucides. Virology. 353(2). 482–490. 5 indexed citations
6.
Otero, Miguel, Giuseppe Nunnari, Julie Sullivan, et al.. (2003). Peripheral Blood Dendritic Cells Are Not a Major Reservoir for HIV Type 1 in Infected Individuals on Virally Suppressive HAART. AIDS Research and Human Retroviruses. 19(12). 1097–1103. 45 indexed citations
7.
Mascio, Michele Di, Geethanjali Dornadula, Hui Zhang, et al.. (2003). In a Subset of Subjects on Highly Active Antiretroviral Therapy, Human Immunodeficiency Virus Type 1 RNA in Plasma Decays from 50 to <5 Copies per Milliliter, with a Half-Life of 6 Months. Journal of Virology. 77(3). 2271–2275. 50 indexed citations
8.
Nunnari, Giuseppe, Miguel Otero, Geethanjali Dornadula, et al.. (2002). Residual HIV-1 disease in seminal cells of HIV-1-infected men on suppressive HAART: latency without on-going cellular infections. AIDS. 16(1). 39–45. 50 indexed citations
9.
Kulkosky, Joseph, Derek M. Culnan, Jeanette Roman, et al.. (2001). Prostratin: activation of latent HIV-1 expression suggests a potential inductive adjuvant therapy for HAART. Blood. 98(10). 3006–3015. 282 indexed citations
10.
Dornadula, Geethanjali, Giuseppe Nunnari, Jeanette Roman, et al.. (2001). Human Immunodeficiency Virus Type 1–Infected Persons with Residual Disease and Virus Reservoirs on Suppressive Highly Active Antiretroviral Therapy Can Be Stratified into Relevant Virologic and Immunologic Subgroups. The Journal of Infectious Diseases. 183(11). 1682–1687. 45 indexed citations
11.
Zhang, H, Geethanjali Dornadula, Jan M. Orenstein, & R J Pomerantz. (2000). Morphologic changes in human immunodeficiency virus type 1 virions secondary to intravirion reverse transcription: evidence indicating that reverse transcription may not take place within the intact viral core.. PubMed. 3(3). 165–72. 37 indexed citations
13.
Dornadula, Geethanjali. (1999). Residual HIV-1 RNA in Blood Plasma of Patients Taking Suppressive Highly Active Antiretroviral Therapy. JAMA. 282(17). 1627–1627. 374 indexed citations
14.
Bagasra, Omar, Robert M. Steiner, Samir K. Ballas, et al.. (1998). Viral Burden and Disease Progression in HIV-1–Infected Patients with Sickle Cell Anemia. American Journal of Hematology. 59(3). 199–207. 27 indexed citations
15.
Zhang, Hui, et al.. (1998). Human Immunodeficiency Virus Type 1 in the Semen of Men Receiving Highly Active Antiretroviral Therapy. New England Journal of Medicine. 339(25). 1803–1809. 332 indexed citations
16.
Dornadula, Geethanjali, David T. Dicker, James A. Hoxie, et al.. (1998). Chemokine Receptors and the Molecular Basis for Human Immunodeficiency Virus Type 1 Entry into Peripheral Hematopoietic Stem Cells and Their Progeny. The Journal of Infectious Diseases. 178(6). 1623–1634. 9 indexed citations
17.
Duan, Lingxun, Huizhong Zhang, Baocheng Hu, et al.. (1998). Intracellular Expression of Single-Chain Variable Fragments To Inhibit Early Stages of the Viral Life Cycle by Targeting Human Immunodeficiency Virus Type 1 Integrase. Journal of Virology. 72(4). 3505–3505. 5 indexed citations
18.
Zhang, Hui, Geethanjali Dornadula, & R J Pomerantz. (1998). Natural endogenous reverse transcription of HIV type 1.. PubMed. 14 Suppl 1. S93–5. 12 indexed citations
19.
Dornadula, Geethanjali, Hui Zhang, Omar Bagasra, & Roger J. Pomerantz. (1997). Natural Endogenous Reverse Transcription of Simian Immunodeficiency Virus. Virology. 227(1). 260–267. 10 indexed citations
20.
Zhang, H, et al.. (1996). Amphipathic domains in the C terminus of the transmembrane protein (gp41) permeabilize HIV-1 virions: a molecular mechanism underlying natural endogenous reverse transcription.. Proceedings of the National Academy of Sciences. 93(22). 12519–12524. 39 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026